Coronary Artery Bypass Grafting Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The global CABG market covers the full range of products and services associated with coronary artery bypass surgery, including surgical instruments, arterial and venous grafts, anastomotic devices, catheters, and intraoperative imaging systems. The two principal surgical approaches are traditional on-pump CABG, performed with cardiopulmonary bypass, and off-pump beating-heart surgery, which avoids the heart-lung machine. Minimally invasive and robotic-assisted variants are expanding their footprint, particularly at high-volume cardiac centers.

• •Market valued at approximately $16.17 billion in 2025; projected to reach roughly $27-34 billion by the early 2030s across various forecast sources
• •Growth rates reported across sources range from approximately 2.9% to 9.7% CAGR, with a 6.9% annual growth rate widely referenced in current market assessments
• •Product categories span surgical instruments, vascular grafts, anastomotic devices, and intraoperative visualization systems

The fundamental driver of market expansion is the rising global burden of coronary artery disease, linked to sedentary lifestyles, poor dietary habits, diabetes, and hypertension across aging populations. Technological innovation plays a critical supporting role, with robotic-assisted surgery, advanced graft materials, and refined perioperative protocols reducing complication rates and shortening recovery times. Wider adoption of these technologies effectively enlarges the treatable patient pool and justifies continued investment in cardiac surgical infrastructure.

• •Cardiovascular disease remains the leading cause of death globally, with ischemic heart disease driving steady procedural volume growth
• •Aging demographics, especially in developed and emerging economies, steadily increase the pool of candidates requiring surgical revascularization
• •Technological advances in robotic platforms, imaging guidance, and biocompatible graft materials improve clinical outcomes and procedural adoption

The market is commonly segmented by product type, surgical instruments, vascular grafts, and accessories, and by surgical approach: on-pump, off-pump, and minimally invasive procedures. North America represents the largest regional market, supported by high cardiovascular disease prevalence, advanced hospital infrastructure, and widespread insurance coverage for surgical revascularization. The Asia-Pacific region is emerging as the fastest-growing geography, fueled by healthcare infrastructure expansion and rising disease burden in China, India, and Southeast Asian nations, while Europe maintains a mature but steady demand profile.

• •North America dominates the global market, with the United States accounting for the largest national share
• •Asia-Pacific is the fastest-expanding region, driven by infrastructure development and growing cardiovascular disease incidence
• •Europe represents a stable, mature market with incremental growth supported by aging populations and established clinical pathways

What are the recent trends and outlook?

Hybrid revascularization strategies, combining CABG with percutaneous coronary intervention, are gaining clinical momentum as a way to optimize outcomes for complex multivessel disease. Robotic-assisted and totally endoscopic CABG procedures are steadily migrating from niche centers to broader adoption as surgeon experience grows and platforms mature. Long-term, the market is expected to benefit from the cumulative effect of disease prevalence, aging demographics, and the slow but persistent diffusion of advanced surgical platforms, with global market size projected in the range of $27 billion to $34 billion by the early 2030s.

• •Hybrid revascularization, integrating surgical and interventional approaches, is emerging as a preferred strategy for complex coronary disease
• •Robotic-assisted and minimally invasive CABG adoption is increasing as technology improves and surgeon training expands beyond leading centers
• •Projected market size in the early 2030s ranges from approximately $27 billion to $34 billion, with Asia-Pacific positioned as the fastest-growing regional contributor